stockportfolio.pro
Stocks / RMD vs WST
RMD vs WST
ResMed Inc. and West Pharmaceutical Services, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| ResMed Inc. (RMD) | West Pharmaceutical Services, Inc. (WST) | |
|---|---|---|
| Market cap | $28.0B | $23.4B |
| Revenue (latest FY) | $5.15B | $3.07B |
| Net income (latest FY) | $1.40B | $493.70M |
| Revenue growth (5y CAGR) | 11.7% | 7.4% |
| Net margin | 27.2% | 16.1% |
| Return on equity | 23.5% | 15.5% |
| P/E ratio | 18.6 | 44.4 |
| Dividend yield | 1.2% | 0.3% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open RMD — free Open WST — freeFrequently asked questions
Which is bigger, RMD or WST?
ResMed Inc. is larger by market capitalization — $28.0B versus $23.4B.
Which grows faster, RMD or WST?
Over the last five fiscal years, ResMed Inc. grew revenue faster — 11.7%/yr versus 7.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.